Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma

被引:0
|
作者
Qing Pang [1 ]
Ling-Qiang Zhang [1 ]
Rui-Tao Wang [1 ]
Jian-Bin Bi [1 ]
Jing-Yao Zhang [1 ]
Kai Qu [1 ]
Su-Shun Liu [1 ]
Si-Dong Song [1 ]
Xin-Sen Xu [1 ]
Zhi-Xin Wang [1 ]
Chang Liu [1 ]
机构
[1] Department of Hepatobiliary Surgery,the First Affiliated Hospital of Medical College,Xi’an Jiaotong University
基金
中国国家自然科学基金;
关键词
Platelets; Lymphocyte; Gallbladder carcinoma; Prognosis; Survival;
D O I
暂无
中图分类号
R735.8 [胆囊、胆道肿瘤];
学科分类号
100214 ;
摘要
AIM:To preliminarily investigate the prognostic significance of the platelet to lymphocyte ratio(PLR) in patients with gallbladder carcinoma(GBC).METHODS:Clinical data of 316 surgical GBC patients were analyzed retrospectively,and preoperative serum platelet and lymphocyte counts were used to calculate the PLR.The optimal cut-off value of the PLR for detecting death was determined by the receiver operating characteristic(ROC) curve.The primary outcome was overall survival,which was estimated by the Kaplan-Meier method.The log-rank test was used to compare the differences in survival.Then,we conducted multivariate Cox analysis to assess the independent effect of the PLR on the survival of GBC patients.RESULTS:For the PLR,the area under the ROC curve was 0.620(95%CI:0.542-0.698,P = 0.040) in detecting death.The cut-off value for the PLR was determined to be 117.7,with 73.6% sensitivity and 53.2% specificity.The PLR was found to be significantlypositively correlated with CA125 serum level,tumornode-metastasis(TNM) stage,and tumor differentiation.Univariate analysis identified carcinoembryonic antigen(CEA),CA125 and CA199 levels,PLR,TNM stage,and the degree of differentiation as significant prognostic factors for GBC when they were expressed as binary data.Multivariate analysis showed that CA125 > 35 U/mL,CA199 > 39 U/mL,PLR ≥ 117.7,and TNM stage Ⅳ were independently associated with poor survival in GBC.When expressed as a continuous variable,the PLR was still an independent predictor for survival,with a hazard ratio of 1.018(95%CI:1.001-1.037 per 10-unit increase,P = 0.043).CONCLUSION:The PLR could be used as a simple,inexpensive,and valuable tool for predicting the prognosis of GBC patients.
引用
下载
收藏
页码:6675 / 6683
页数:9
相关论文
共 50 条
  • [21] Utility of MPV, MPV/Platelet Ratio, RDW, RDW/Platelet Ratio, Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and as Diagnostic and Prognostic Markers in Patients with Hepatocellular Carcinoma.
    Srikanth, V. S.
    Krishna, Pillai M. Gopala
    INTERNIST, 2019, 60 : S57 - S57
  • [22] Neutrophil lymphocyte ratio and Platelet lymphocyte ratio as a prognostic factor in brain metastases
    Niiya, A.
    Murakami, K.
    Kobayashi, R.
    Toyofuku, K.
    Nishimura, E.
    Kato, M.
    Ozawa, Y.
    Shinjo, H.
    Miyaura, K.
    Morota, M.
    Serizawa, T.
    Ito, Y.
    Imai, A.
    Kagami, Y.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S384 - S385
  • [23] Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio
    Sun, Wei
    Zhang, Linli
    Luo, Min
    Hu, Guangyuan
    Mei, Qi
    Liu, Dongbo
    Long, Guoxian
    Hu, Guoqing
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1332 - E1340
  • [24] The prognostic significance of neutrophil to lymphocyte ratio and platelet count in patients with metastatic urothelial carcinoma
    Su, Y. L.
    ANNALS OF ONCOLOGY, 2015, 26 : 72 - 72
  • [25] Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma
    Li, Xing
    Chen, Zhan-Hong
    Xing, Yan-Fang
    Wang, Tian-Tian
    Wu, Dong-Hao
    Wen, Jing-Yun
    Chen, Jie
    Lin, Qu
    Dong, Min
    Wei, Li
    Ruan, Dan-Yun
    Lin, Ze-Xiao
    Wu, Xiang-Yuan
    Ma, Xiao-Kun
    TUMOR BIOLOGY, 2015, 36 (04) : 2263 - 2269
  • [26] Utility of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Mean Platelet Volume as diagnostic and prognostic markers in patients with Hepatocellular carcinoma, Prostate carcinoma, Stomach carcinoma, Aplastic Anemia
    Srikanth, V. S.
    Pillai, M. G. K.
    INTERNIST, 2018, 59 : S18 - S18
  • [27] Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma
    Yapar, Aliekber
    Tokgoz, Mehmet Ali
    Yapar, Dilek
    Atalay, Ismail Burak
    Ulucakoy, Coskun
    Gungor, Bedii Safak
    JOINT DISEASES AND RELATED SURGERY, 2021, 32 (02): : 489 - 496
  • [28] Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancer
    Mady, Mohamed
    Prasai, Kritika
    Tella, Sri H.
    Yadav, Siddhartha
    Hallemeier, Christopher L.
    Rakshit, Sagar
    Roberts, Lewis
    Borad, Mitesh
    Mahipal, Amit
    HPB, 2020, 22 (10) : 1490 - 1495
  • [29] Prognostic Value of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Head and Neck Malignancies
    Yanish Bhashkar Seetohul
    Vishwambhar Singh
    Rajiv Kumar Jain
    Ashvanee Kumar Chaudhary
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2020, 72 : 128 - 132
  • [30] The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
    Wang, Jing-Houng
    Chen, Yen-Yang
    Kee, Kwong-Ming
    Wang, Chih-Chi
    Tsai, Ming-Chao
    Kuo, Yuan-Hung
    Hung, Chao-Hung
    Li, Wei-Feng
    Lai, Hsiang-Lan
    Chen, Yen-Hao
    CANCERS, 2022, 14 (02)